Humana (HUM)
Technical, fundamental, and sentiment analysis with recent related videos.
HUM rates Neutral overall. The fundamental read is neutral: the company passes 6 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 5.04); revenue is growing about 11.8% per year; net income is declining about 21.5% per year. The technical picture is bullish: price is 36.8% above the 200-day moving average; 4.7% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bearish (composite 22/100), based on 4 news articles and 1 TV segment from recent coverage.
Revenue 3-year avg +11.8%. Net income 3-year avg -21.5%.
Price vs 20DMA +1.6%. RSI 53.97. Bollinger state: Inside Bands.
Composite score 22/100 from the AI judge, based on 4 news items, 1 television segments, and 0 videos.
Latest Market Read
Fundamental sits Neutral because revenue averaged 11.8 percent per year while net income averaged -21.5 percent per year, with net income carrying slightly more weight. Technical is Bullish: the stock trades about 1.6 percent above its 20-day moving average, the Relative Strength Index (RSI), a momentum reading, is 54, and price is inside the Bollinger Bands (a volatility channel), though MACD below its signal and below-average volume temper conviction. Sentiment is Bearish, composite 22/100, and that negative sentiment offsets technical strength so the overall rating is Neutral.
Recent news: GDELT (Global Database of Events, Language, and Tone) articles report Humana and UnitedHealthcare are discontinuing Medicare Advantage PPO plans, affecting about 1 million enrollees and citing higher costs and rising utilization, a move said to pressure enrollment, revenue, and margins. Internet Archive TV coverage urged dual-eligible beneficiaries to enroll in a Humana Medicare Advantage plan with over-the-counter allowances before the Dec. 7 deadline. Recent videos emphasize Humana’s Medicare star-rating upgrades and several analyst upgrades and price-target hikes that spurred stock rallies.